EYENOVIA INC. - COMMO

Eyenovia Announces Positive Results from VISION-2 Phase 3 Study of MicroLine as a Potential On-Demand Treatment for Presbyopia

20 Oct 2022 08:00:02 By Nasdaq GlobeNewswire

Eyenovia Announces Planned Retirement of Lead Independent Director Ken Lee, Jr.

30 Sep 2022 08:00:00 By Nasdaq GlobeNewswire

Eyenovia to Present at Upcoming Healthcare Conferences

07 Sep 2022 08:00:03 By Nasdaq GlobeNewswire

Eyenovia to Participate in Multiple Medical Meetings in September

06 Sep 2022 08:00:03 By Nasdaq GlobeNewswire

Eyenovia Reports Second Quarter 2022 Financial Results

10 Aug 2022 16:05:01 By Nasdaq GlobeNewswire

Eyenovia to Report Second Quarter 2022 Results on Wednesday, August 10

04 Aug 2022 08:00:02 By Nasdaq GlobeNewswire

Eyenovia Announces Appointment of Ophthalmic Industry Veteran Michael Rowe as Chief Executive Officer and Board Member

27 Jul 2022 08:00:03 By Nasdaq GlobeNewswire

Eyenovia Provides Manufacturing Update and Announces Appointment of Bren Kern as SVP of Manufacturing and Operations

18 Jul 2022 08:00:01 By Nasdaq GlobeNewswire

Eyenovia Announces Appointments of Dr. Ellen Strahlman and Dr. Ram Palanki as New and Independent Members of its Board of Directors

07 Jul 2022 08:00:01 By Nasdaq GlobeNewswire

Eyenovia Strategic Partner Arctic Vision Enrolls First Patient in Phase III Clinical Trial of ARVN003 (MicroLine) for Presbyopia in China

06 Jul 2022 08:00:02 By Nasdaq GlobeNewswire

UPDATE: Eyenovia Announces Virtual 2022 Annual Meeting of Stockholders

09 Jun 2022 10:09:12 By Nasdaq GlobeNewswire

Eyenovia Announces Virtual 2022 Annual Meeting of Stockholders

09 Jun 2022 08:00:01 By Nasdaq GlobeNewswire

Eyenovia Announces Planned Chief Executive Officer Transition

07 Jun 2022 08:00:01 By Nasdaq GlobeNewswire

Eyenovia Reports First Quarter 2022 Financial Results

12 May 2022 16:05:01 By Nasdaq GlobeNewswire

Eyenovia to Report First Quarter 2022 Results on Thursday, May 12

05 May 2022 08:00:03 By Nasdaq GlobeNewswire

Eyenovia CEO, CMO and Chairman Dr. Sean Ianchulev to Present at Eyecelerator @ American Society of Cataract and Refractive Surgery (ASCRS) 2022

20 Apr 2022 08:00:00 By Nasdaq GlobeNewswire

Eyenovia Announces Poster Presentation at the 2022 American Society of Cataract and Refractive Surgery Annual Meeting

19 Apr 2022 08:00:01 By Nasdaq GlobeNewswire

Eyenovia Reports Fourth Quarter and Full Year 2021 Financial Results

28 Mar 2022 16:05:00 By Nasdaq GlobeNewswire

Eyenovia to Report Fourth Quarter and Full Year 2021 Results on Monday, March 28

21 Mar 2022 08:00:01 By Nasdaq GlobeNewswire

Eyenovia Announces Positive Study Results Demonstrating that its Optejet® Delivery Technology Reduces Conjunctival Cell Toxicity from Preserved Ophthalmic Solutions to a Level Comparable with Non-Preserved Solutions

15 Mar 2022 08:00:01 By Nasdaq GlobeNewswire